Dolomite Bio, a leading provider of high throughput single-cell technology, today announced an update to their single cell RNA-Seq (scRNA-Seq) and single nuclei RNA-Seq (sNuc-Seq) protocols.
Dolomite Bio, a leading provider of high throughput single cell technology today announced the launch of a new application note demonstrating agarose encapsulation with the Nadia Innovate. Hydrogel droplets, such as those made of agarose, represent a potent solution for many single cell applications.
Dolomite Bio’s Nadia Instrument is helping researchers to gain a deeper understanding of motor neuron disease through the use of single nuclei RNA sequencing (sNuc-Seq). This automated, microfluidic droplet-based platform allows flexible encapsulation of up to eight samples in parallel in under 20 minutes, helping to accelerate studies and generate high quality data.
In his AGBT 2019 presentation, PacBio’s Jason Underwood shared results of a collaborative project using Dolomite Bio’s Nadia Instrument together with the PacBio Sequel System for single cell isoform sequencing.
Dolomite Bio has decided to transfer the µencapsulator system to their sister brand, Dolomite Microfluidics - an expert in microfluidic technology. This decision enables Dolomite Bio to have an enhanced commercial focus on their newest product range - the Nadia Product family.